Compare Intuitive Surgical, Inc. (ISRG) vs Lemonade Inc (LMND) Price & Performance

Intuitive Surgical (ISRG) trades at $350.06, down 1.34% on the day and near its 52-week low of $344.55. The stock is in a bearish technical trend despite strong fundamentals: Q2 2026 EPS beat estimates at $2.80 vs. $2.48 expected, revenue grew to $10.06B in 2025, and net income margin expanded to 28.45%. However, slowing U.S. procedure growth and a cautious 2026 outlook have pressured shares, with recent news highlighting a nearly 40% decline year-to-date.

The outlook remains mixed: robust profitability and a 69.6% analyst buy rating with a $504.56 consensus target suggest long-term value, but near-term risks include valuation concerns (P/E 40.5), competitive pressures, and macroeconomic headwinds. Investors face a divergence between solid execution and market sentiment driven by growth deceleration fears.

Lemonade (LMND) trades at $68.62, up 2.14% today, with a neutral technical signal and bullish moving averages. Revenue growth is strong, reaching $737.90 million in 2025, but the company remains unprofitable with a net income margin of -22.43%. Recent news highlights expansion into new states and a renegotiated reinsurance program, while analysts are divided with a consensus price target of $69.60.

The outlook hinges on Lemonade's path to profitability, with guidance for positive adjusted EBITDA by year-end. Opportunities include accelerating top-line growth and AI-driven efficiency, but risks persist from sustained losses, competitive pressures, and execution challenges. The stock's valuation at a P/S of 5.97 reflects growth expectations amid uncertainty.